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ABSTRACT
Background: Cluster analyses were previously performed to identify asthma phenotypes underlying asthma
syndrome. Although a large number of patients with asthma develop the disease later in life, these previous
cluster analyses focused mainly patients with younger-onset asthma.
Methods: Cluster analysis examined the existence of distinct phenotypes of late-onset asthma in Japanese
patients with adult asthma. We then associated genotypes at the CCL5, TSLP, IL4, and ADRB2 genes with the
clusters of asthma identified.
Results: Using the 8 variables of age, sex, age at onset of the disease, smoking status, total serum IgE,
%FEV1, FEV1FVC, and specific IgE responsiveness to common inhaled allergens, two-step cluster analysis of
880 Japanese adult asthma patients identified 6 phenotypes: cluster A (n = 155): older age at onset, no airflow
obstruction; cluster B (n = 170): childhood onset, normal-to-mild airflow obstruction; cluster C (n = 119): child-
hood onset, the longest disease duration, and moderate-to-severe airflow obstruction; cluster D (n = 108): older
age at onset, severe airflow obstruction; cluster E (n = 130): middle-age at onset, no airflow obstruction; and
cluster F (n = 198): older age at onset, mild-to-moderate airflow obstruction. The CCL5-28C>G genotype was
significantly associated with clusters A, B and D (OR 1.65, p = 0.0021; 1.67, 0.018; and 1.74, 0.011, respec-
tively). The ADRB2 Arg16Gly genotype was also associated with clusters B and D (OR 0.47, p = 0.0004; and
0.63, 0.034, respectively).
Conclusions: The current cluster analysis identified meaningful adult asthma phenotypes linked to the func-
tional CCL5 and ADRB2 genotypes. Genetic and phenotypic data have the potential to elucidate the pheno-
typic heterogeneity and pathophysiology of asthma.
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INTRODUCTION
Asthma describes a clinical syndrome that can be
caused by a number of different pathologies, rather
than a single disease. The phenotype is described as
the clinical, physiological, morphological, and bio-
chemical characteristics of a subtype of the disease
that result from the interaction between genes and
the environment. Clinical or physiological pheno-
types relevant to asthma include those defined by the
presence of allergic diathesis, presence of chronic air-
flow obstruction, frequency of exacerbations, age of
asthma onset, and response to asthma therapy.
Asthma phenotypes may also be identified as clusters
of measurements from different dimensions of the
disease (ie, the clinical features, physiology, immu-
nology, pathology, hereditary components, environ-
mental influences, response to treatment, and so
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forth). A large-scale cluster analysis was performed
on 726 patients with asthma in the Severe Asthma Re-
search Program (SARP).1 This study used 628 vari-
ables compressed into 34 weighted variables and
identified 5 separate clusters. The strongest predic-
tors were FEV1% and age at onset. Another cluster
analysis cohort revealed similar findings.2 Latent
class analysis, a clustering model-based method, ap-
plied in 2 large epidemiological studies conducted in
patients with adult asthma, also identified 4 asthma
phenotypes.3
Although these previous cluster analyses focused
mainly on patients with younger-onset asthma (age of
asthma onset <20 years), asthma can develop at any
stage of life and asthma phenotypes show age-related
variations,4 suggesting that adult-onset asthma may
constitute some distinct phenotypes of asthma. In
fact, we previously reported that the gain-of-function
-28G allele of the promoter SNP (rs2280788: -28C>G)
in the CCL5 gene is associated with susceptibility to
late-onset asthma in patients who developed asthma
at age >40 years5 and with variable expression of em-
physema in patients with COPD.6 The development
of asthma in older adults is also influenced by smok-
ing; compared with younger adults with asthma (18-
34 years), older adults with asthma were more likely
to report a history of smoking (54% vs. 34%).7 Al-
though previously reported cluster analyses did not
include patients with asthma who have smoked, pos-
sible pathophysiological mechanisms underlying
smoking asthma deserves further medical and re-
search attention.
Unsupervised cluster analysis is a useful tool for
identifying phenotypes; however, it has not been ap-
plied to adult-onset patients with persistent asthma
across a wide range of severities. In addition, a clus-
ter, which describes “observable characteristics,”
does not necessarily relate to or give any insight into
the underlying disease processes that are defined by
a distinct functional or pathophysiological mecha-
nism. Therefore, given the previous cluster analyses
that emphasized the importance of age of asthma on-
set in distinguishing asthma clusters, we here investi-
gated the presence of distinct adult-onset asthma phe-
notypes by applying a clustering method to a well-
characterized asthma cohort of Japanese adults. We
then searched for the phenotype-genotype correla-
tions by examining the influence of functional geno-
types at the CCL5, TSLP, IL4, and ADRB2 genes on
the expression of the particular clusters of asthma
identified.
METHODS
STUDY SUBJECTS
This study was a cross-sectional analysis to identify
asthma phenotypes, comprising 880 patients with
asthma and 1329 healthy controls. Asthma was de-
fined on the basis of recurrent episodes of at least 2
of 3 symptoms (cough, wheeze, or dyspnea) associ-
ated with demonstrable reversible airflow limitation
(15% variability in FEV1 or in peak expiratory flow
rate either spontaneously or with an inhaled, short-
acting β2-agonist) or with increased airway respon-
siveness to methacholine, or with both, as described
elsewhere.8 All patients (N = 880) were diagnosed as
having asthma by respiratory diseases physicians at
University of Tsukuba Hospital, Hokkaido University
Hospital, or their affiliated hospitals. All patients had
asthma symptoms deemed by their physician to re-
quire initiation of asthma-controller therapy. Patients
with asthma in the study had persistent asthma with
variable airflow limitation and their pulmonary func-
tions with asthma medication were measured at base-
line. Because smoking prevalence remains high in Ja-
pan and the prevalence rates of smoking in subjects
with asthma have also been reported to be similar to
those in the general population,9,10 the current study
included asthma patients with a history of smoking so
as not to exclude the diverse patient populations seen
in clinical practice. The data for age at onset of
asthma were self-reported. To judge the age at onset
of asthma as accurately as possible, patients were
asked about episodes of dyspnea, wheezing, or cough
they had experienced during childhood and puberty.
In cases of uncertainty, the time of the earliest respi-
ratory symptoms was designated as the age at onset
of asthma symptoms, and used for the calculation of
the duration of asthma. Of the 880 asthmatic patients,
298 were previously also studied in our case-control
study of the CCL5 -28C>G SNP.5 The remaining pa-
tients were newly recruited.
Details of the non-asthmatic healthy subject re-
cruitment (N = 1329) have been reported previ-
ously.11 Briefly, detailed information on respiratory
health, lifestyle, and exposure conditions to environ-
mental irritants such as tobacco smoke, allergens,
and air pollution was collected. Lung function data,
chest radiographic findings, and results of a standard
clinical examination were also available. On the basis
of a detailed questionnaire on pulmonary symptoms,
a physical examination, chest roentgenogram and
lung function data, we carefully excluded the pres-
ence of pulmonary diseases such as asthma and
COPD. Atopy was assessed by measurement of spe-
cific IgE responsiveness to 14 common inhaled aller-
gens including Dermatophagoides farinae, grass pol-
lens, animal dander, and molds. We defined atopy as
a positive response to at least 1 of the 14 allergens.
The protocol was approved by the ethics commit-
tees of all the participating hospitals, and written in-
formed consent was obtained from all the partici-
pants.
ALLELE-SPECIFIC PCR AND DETECTION OF
FLUORESCENCE-LABELED PCR FRAGMENTS
Five common SNPs at the CCL5 (rs2280788), TSLP
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(rs3806933 and rs2289276), IL4 (rs2070874) and
ADRB2 (rs1042713, Arg16Gly) genes were geno-
typed using a TaqMan assay (Applied Biosystems,
Foster City, CA, USA) combined with a kinetic allele-
specific polymerase chain reaction, as described pre-
viously.11 These 5 SNPs have been demonstrated to
be of functional relevance, and have been consis-
tently associated with asthma or asthma-related phe-
notypes.5,12-15
STATISTICAL ANALYSIS
Statistical analysis was carried out with SPSS version
19 software (SPSS, Chicago, IL, USA) for the cluster,
discriminate, and logistic regression analyses. Clus-
ter analysis is a technique that defines the distances
of subjects from each other based on the combined
values multidimensional vector of the subjects’ meas-
ured characteristics. It can be used to describe the
phenotypes of a disease without the need for histori-
cal or arbitrary a priori assumptions about classifica-
tion. We applied a uniform cluster analysis methodol-
ogy to the asthma population (N = 880) using a two-
step approach. In the first step, hierarchical cluster
analysis using Ward’s method generated a dendro-
gram for estimation of the number of likely clusters
within the studied population. This estimate was pre-
specified in a k-means cluster analysis that was used
as the principal clustering technique.16 On the basis
of previous reports that consistently revealed the
strongest discriminatory variables for cluster assign-
ment including age at onset, lung function, and IgE
responsiveness,1-3 we decided to apply a rather bi-
ased hypothesis-driven approach to identify asthma
phenotypes by selecting 8 factors for estimation that
may contribute to characterizing asthma phenotypes.
Complete data for age, sex, smoking status (current,
past or never), age at onset, total IgE levels, atopic
status (specific IgE responsiveness to common in-
haled allergens), baseline FEV1, and FEV1FVC were
available for all of the 880 patients with asthma. We
did not include BMI in the cluster analysis because
obese female patients with asthma are comparatively
rare in Japan, and we also wanted to avoid subject
drop-out due to an incomplete dataset for BMI. The
natural logarithm of serum IgE was standardized us-
ing the Z score.
To compare differences between 1329 healthy con-
trols and 880 patients with asthma, and to compare
between clusters, one-way analysis of variance
(ANOVA), the Kruskal-Wallis test, and the χ2 test
were used for parametric continuous, nonparametric
continuous and categorical variables, respectively. To
determine the strongest predictors of cluster assign-
ment, stepwise discriminant analysis of the cluster
variables was performed using Wilks’ lambda as the
statistic, an F value of 3.84 as the criterion for deter-
mining entry into the model, and an F value of 2.71
for determining removal from the model.
For the classification and regression tree (CART)
analysis,17 2 strongest discriminators (age at onset
and %FEV1) were included in the determination of the
model. CART analysis involves binary recursive parti-
tioning, which splits a single parent node into two
daughter nodes based on the predictor variable that
best stratifies the population into groups with and
without the outcome of interest. Each daughter node
can be split further into two nodes, and so on. CART
was generated through the rpart package [version
3.1-54] incorporated in the R package [version
2.14.0].
To search for phenotype-genotype correlations, we
studied 4 candidate genes that could affect the devel-
opment of distinct asthma phenotypes. These candi-
date genes include CCL5, TSLP, IL4, and ADRB2.
We examined the genetic effects of 5 functional SNPs
at these genes on the development of each asthma
phenotype using multinomial logistic regression
analysis. For these case-control analyses, we used
1329 healthy adults as a reference. We adjusted the
analysis for possible confounding factors such as age,
sex, smoking status (never, past, or current), and log
total serum IgE.
RESULTS
Our dataset included 880 asthmatics ranging in age
from 16 to 84 years (Table 1). In the first step, hierar-
chical clustering using Ward’s minimum-variance
method generated a dendrogram, which indicated 6
clusters within the studied population. As a second
step, k-means cluster analysis was performed using
this estimated number of clusters. The demographic
characteristics of each cluster are shown in Table 2.
Age, sex, age at onset, duration of the disease, total
serum IgE, atopic status, FEV1FVC, %FEV1, and
smoking status were all significantly different (p <
0.0001) among these 6 clusters.
Cluster A (n = 155, median age 65.0 years) was
characterized by the oldest age at onset, the shortest
duration, normal lung function, the lowest levels of to-
tal IgE, the lowest sensitizations to inhaled allergens
(atopy), and the lowest prevalence of smokers (late-
onset mild less-atopic asthma). Cluster B was the sec-
ond largest group (n = 170, 28.5 years). It was charac-
terized by young atopic individuals and childhood on-
set with long disease duration (early-onset mild
atopic asthma). Despite the rather long disease dura-
tion (median, 20 years) and large number of smokers
(34.7%), this group was distinguished by retained
lung function (%FEV1, 85.7%; FEV1FVC, 79.3%).
Cluster C (n = 119, 37.0 years) was a male-dominant
group characterized by early-onset atopic asthma
with the longest disease duration (22 years) and the
largest number of smokers (42.0%). Compared with
cluster B, this group had lower %FEV1 (59.3%) and
FEV1FVC (58.4%) (early-onset moderate-to-severe
atopic asthma). Cluster D (n = 108, 61.0 years) was
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Table　1　Characteristics of the study population
Healty Control Subjects Patients with Asthma p value*
Number of subjects 1329 880
Sex (female, %) 713 (53.6) 515 (58.5) 0.013
Age, y (range) 51.0 (22-78) 54.0 (16-84) 0.029
Smoker (past or current, %) 494 (37.2) 319 (36.2) 0.108
†Smoking pack-year: 0 835 (62.8) 561 (76.0) <0.0001
(%): 0-10 165 (12.4) 81 (11.0)
: >10 329 (24.8) 96 (13.0)
‡Atopy (%) 786 (59.1) 624 (70.9) <0.01
Serum IgE (log, SD) 1.78 (0.58) 2.30 (0.64) <0.0001
FEV1 % pred (%, SD) 91.6 (13.0) 80.6 (23.4) <0.0001
FEV1/FVC (%, SD) 83.0 (5.8) 70.3 (12.9) <0.0001
§BMI (kg/m2, SD) 23.0 (3.1) 23.4 (3.8) 0.008
*χ2 test, analysis of variance, or Kruskal-Wallis test was used where appropriate.
†Information about smoking pack-year was available for 738 patients with asthma.
‡Atopy: specifi c IgE responsiveness to common inhaled allergens.
§Information about BMI was available for 649 patients with asthma.
FEV1, forced expiratory volume; FVC, forced vital capacity; % pred, % predicted.
Table　2　Characteristics of the asthma population
Late-Onset
Mild
Less-Atopic
Early-Onset
Mild
Atopic
Early-Onset
Moderate-to-Severe
Atopic
Late-Onset
Severe
Middle-Age Onset
Female-Dominant
Late-Onset
Moderate
Less Atopic
cluster A cluster B cluster C cluster D cluster E cluster F p value*
Number of subjects 155 170 119 108 130 198
Sex (female, %) 66.5 51.2 39.5 55.6 70 64.1 <0.000
Age (y)
(range)
65.5
(50-84)
31.2
(16-78)
40.5
(17-79)
62.8
(43-84)
41.7
(21-73)
60.0
(39-83)
<0.000
†BMI 23.9 23.7 23.8 22.6 23.0 23.4 0.10
BMI >30 (%) 5.1 11.1 5.3 2.3 5.3 5.1 0.26
Age onset (y)
(range)
58.0
(20-80)
5.0
(0-30)
13.0
(0-36)
49.0
(20-78)
33.0
(5-50)
52.5
(25-82)
<0.000
Duration (y)
(range)
5.0
(0-60)
20.0
(0-71)
22.0
(0-73)
10.0
(0-61)
4.0
(0-63)
5.0
(0-41)
<0.000
FEV1 % pred (%)
(SD)
108.2
(12.6)
85.7
(12.5)
53.9
(12.6)
48.3
(10.0)
98.3
(13.0)
76.5
(8.8)
<0.000
FEV1/FVC (%)
(SD)
75.9
(7.8)
79.3
(8.1)
58.4
(9.1)
52.4
(9.1)
80.7
(7.6)
68.1
(8.3)
<0.000
Serum IgE (log) 2.02 2.57 2.43 2.26 2.20 2.31 <0.000
Atopy (%) 52.3 95.3 86.6 61.1 74.6 56.9 <0.000
Ever smoker (%) 23.2 34.7 42 40.8 40 40.4 <0.000
‡pack-year: 0 119 (81.0) 111 (82.8) 69 (77.5) 65 (71.4) 78 (72.9) 119 (70.0)
(%): 0-10 11 (7.5) 16 (11.9) 13 (14.6) 7 (7.7) 17 (15.9) 17 (10.0)
: >10 17 (11.5) 7 (5.2) 7 (7.9) 19 (20.9) 12 (11.2) 34 (20.0) <0.010
*χ2 test, analysis of variance, or Kruskal-Wallis test was used where appropriate.
†Information about BMI was available for 649 patients with asthma.
‡Information about smoking pack year was available for 738 patients with asthma.
another late-onset group characterized by the worst
lung function, intermediate duration of the disease
(10 years) (late-onset severe asthma). Cluster E (n =
130, 40.5 years) was a female-dominant group charac-
terized by middle-age onset, short disease duration,
normal lung function, and lower levels of total serum
IgE (middle-age onset female-dominant asthma).
Cluster F (n = 198, 60.0 years) was the largest cluster,
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Fig.　1　Tree analysis. Using two variables (age at onset of asthma and baseline pFEV1), patients 
with adult asthma can be assigned to the 6 clusters; 80.8% of patients are assigned to the correct 
cluster of asthma.
≥27 yrs
≥49 yrs <49 yrs
Cluster A
late-onset mild
Cluster E
middle-onset
female dominant
Cluster F
late-onset
moderate
Cluster D
late-onset severe
Cluster B
early-onset mild
Cluster C
early-onset
moderate-severe
≥90%
<60% ≥70%
90 > ≥ 60%
pFEV1
<27 yrs
<70%
pFEV1
Age Onset
Age Onset
characterized by late onset, mildly decreased lung
function, higher prevalence of smokers, and short
disease duration (late-onset moderate less-atopic
asthma).
A discriminant analysis using the same 8 variables
revealed that the 5 strongest discriminatory variables
for assignment were age at onset of asthma (F value,
219.9), %FEV1 (206.7), FEV1FVC (36.4), age (33.9),
and total serum IgE levels (4.2). Using these 5 vari-
ables, 95.6% of the subjects in the current samples
were assigned to the appropriate cluster. We devel-
oped a CART model, shown in Figure 1. Using the
variables of age at onset and %FEV1, 80.8% of the asth-
matic patients in the current study were assigned to
the appropriate cluster.
The overall success rate for genotyping was 99.0%,
96.7%, 95.2%, 98.0% and 96.8% for the CCL5
(rs2280788), TSLP (rs3806933 and rs2289276), IL4
(rs2070874), and ADRB2 (rs1042713) SNPs, respec-
tively. In the control group (N = 1329), none of the
SNPs deviated from the Hardy-Weinberg equilibrium
(χ2, p > 0.05 for all SNPs). The -28G allele at the CCL5
promoter polymorphism is significantly associated
with late-onset asthma (n = 532, age at onset >40
years) (OR = 1.38 [95%CI: 1.03, 1.85], p = 0.031), repli-
cating our previous finding of the association of this
allele with susceptibility to the development of adult-
onset asthma.5 When the association of this SNP was
evaluated by multinomial logistic regression analysis
according to each of the 6 clusters identified in this
study, significant associations of the -28G allele were
found with clusters A (OR 1.65, p = 0.0021), D (OR
1.74, p = 0.011), and B (OR 1.67, p = 0.018) (Table 3).
In addition, the presence of the ADRB2 Gly16 allele
was inversely associated with clusters B (OR 0.45, p =
0.00040) and D (OR 0.63, p = 0.034). In contrast, nei-
ther the TSLP nor the IL4 SNPs was associated with
any of the asthma clusters, although TSLP rs2289276
was associated with the presence of asthma in the
whole study population (OR = 1.25, p = 0.019).
DISCUSSION
The median age of the subjects in the current study
was 54.0 years, making this study distinct from previ-
ous cluster analyses that studied much younger
asthma populations. Involving adult asthma patients
who developed the disease later in life allowed us to
cover larger ranges of asthma phenotypes. Although
the substantial differences in baseline characteristics
and methodology make it hard to compare the pheno-
types produced directly, it is interesting to compare
our study with the 3 other studies that also used clus-
tering approaches to characterize adult asthma (sum-
marized in Table 4). In those previous studies, there
were no clear clusters that corresponded to the clus-
ters A, D and F identified in the current study, which
were characterized by patients who developed
asthma at an older age. In contrast, it is remarkable
that the clusters described in the previous studies
showed significant overlaps with clusters B and C,
Kaneko Y et al.
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Table　3A　Association of the CCL5 promoter polymorphism with asthma according to clusters
OR†
(95% Cl)
Adjusted OR
(95% Cl) p value*
-28C/G Genotype CC CG GG
Control, N = 1329 984 310 35 reference
Late onset clusters
Cluster A; late-onset mild less-atopic, n = 151  99  47  5 1.50 (1.05-2.14) 1.65 (1.20-2.28) 0.0021
Cluster D; late-onset severe, n = 106  71  30  5 1.41 (0.92-2.15) 1.74 (1.13-2.66) 0.011
Cluster F; late-onset moderate less atopic, n = 193 146  43  4 0.92 (0.65-1.30) 1.06 (0.74-1.53) 0.75
Early onset clusters
Cluster B; early-onset mild atopic, n = 165 116  45  4 1.21 (0.84-1.72) 1.67 (1.09-2.55) 0.018
Cluster C; early-onset moderate-to-severe atopic, n = 116  95  19  2 0.63 (0.39-1.03) 0.68 (0.45-1.05) 0.084
Middle-age onset cluster
Cluster E; middle-age onset female-dominant, n = 126  98  26  2 0.82 (0.53-1.26) 0.99 (0.72-1.37) 0.97
Defi nition of abbreviations: Cl, confi dence interval; OR, odds ratio.
*p value was calculated for adjusted OR.
†Odds ratios (95% Cls) were calculated for the presence of the -28G allele using a multinomial logistic regression model.
In addition to the polymorphism, sex, age, smoking status and log [total serum IgE] were adjusted in the multinomial logistic regression
model.
Some patients with asthma could not be genotyped for technical reasons. The overall success rate for the SNP was 99.0%.
Table　3B　Association of the ADRB2 Arg16Gly polymorphism with asthma according to clusters
OR†
(95% Cl)
Adjusted OR 
(95% Cl) p value*
ADRB2 Arg16Gly Genotype ArgArg ArgGly GlyGly
Control, N = 1329 287 677 322 reference
Late onset clusters
Cluster A; late-onset mild less-atopic, n = 151  32  83  35 1.03 (0.68-1.54) 1.06 (0.74-1.52) 0.74
Cluster D; late-onset severe, n = 106  33  48  27 0.64 (0.41-0.98) 0.63 (0.41-0.97) 0.034
Cluster F; late-onset moderate less atopic,
n = 193
 48  92  54 0.89 (0.62-1.26) 0.85 (0.59-1.23) 0.40
Early onset clusters
Cluster B; early-onset mild atopic, n = 165  54  71  42 0.59 (0.42-0.84) 0.45 (0.29-0.70) 0.00040
Cluster C; early-onset moderate-to-severe atopic, 
n = 116
 25  67  26 1.15 (0.71-1.85) 0.93 (0.61-1.43) 0.76
Middle-age onset cluster
Cluster E; middle-age onset female-dominant,
n = 126
 28  69  28 0.98 (0.63-1.53) 0.82 (0.59-1.14) 0.24
Defi nition of abbreviations: Cl, confi dence interval; OR, odds ratio.
*p value was calculated for adjusted OR.
†Odds ratios (95% Cls) were calculated for the presence of the Gly allele using a multinomial logistic regression model.
In addition to the polymorphism, sex, age, smoking status and log [total serum IgE] were adjusted in the multinomial logistic regression
model.
Some participants could not be genotyped for technical reasons. The overall success ratio for the SNP was 96.8%.
which were characterized by individuals who devel-
oped the disease in early life (early-onset persistent
atopic asthma). Our study is also clearly character-
ized by inclusion of many smokers, reflecting the
complexity and diversity of asthma in the actual clini-
cal setting. Cluster D, characterized by aged smokers
with severe airflow obstruction and a higher than 60%
prevalence of atopy, may demonstrate ”overlap” fea-
tures of asthma and COPD. Conversely, cluster F was
characterized by late-onset asthma with rather pre-
served lung function. Because patients in clusters D
and F had similar intensities of smoking exposure,
patients in cluster F may have been resistant to smok-
ing effects. Although our study population showed no
difference in BMI according to the clusters, cluster E,
which was characterized by middle-age onset, less
atopy, and female dominance, might share some
pathobiological features with a group of nonatopic,
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Table　4　Summary of previous studies
First author (ref.) Our study Moore (1) Haldar (2) Siroux (3)
Severity persistent asthma severe asthma mild asthma refractory asthma mild asthma†
Subjects (N) 880 728‡ 184 187 1895§/641¶
Smoking (%) 36.2 - - - -
BMI (mean) 23.4 29 27.5 28.5 -
Age at onset Lung function
Young onset
(<16 y)
mild cluster B cluster 1 cluster 1 phenotype C/G
moderate cluster 2
severe cluster C cluster 4 cluster 1/cluster 3 phenotype A/E
Middle-age 
onset
mild cluster E cluster 3 phenotype D/H
severe cluster 5 cluster 4 phenotype B/F
Older onset
(40< y)
mild cluster A
moderate cluster F
severe cluster D
Middle-age onset,
obese, female-dominant
cluster 3
(age at onset, 42 y)
cluster 2
(age at onset, 35.3 y)
cluster 2
(age at onset, 15.4 y)
†Subjects who had a wheeze experience were recruited.
‡Severe Asthma Research Program (SARP)
§European Community and Respiratory Health Survey II (ECRHS II)
¶Epidemiological Study on the Genetics and Environment of asthma 2 (EGEA2)
primarily obese women that has been consistently
identified in previous studies.1,2
In the current study, the CCL5 -28G allele was as-
sociated with 3 distinct asthma phenotypes (cluster
A, B and D), whereas the ADRB2 Arg16Gly genotype
influenced the development of 2 distinct asthma phe-
notypes (clusters B and D). Our previous study iden-
tified a significant association of the CCL5 -28C>G
SNP with asthma only in individuals who developed
the disease after the age of 40 years5 and with non-
emphysematous COPD.6 However, genetic associa-
tions between early-onset atopic asthma and the
CCL5 -28C>G genotype have also been reported in
Asian populations,18,19 possibly reflecting the genetic
heterogeneity among different ethnicities and differ-
ent asthma severities. In the ADRB2 gene, Arg16Gly
and Glu27Gln are the two most extensively studied
polymorphisms for asthma-related phenotypes. Nei-
ther polymorphic site has been associated with
asthma per se,20,21 but among asthmatic subjects, the
Gly16 allele has been associated with corticosteroid
use,20 nocturnal asthma22 and severe asthma.23 Sub-
jects who were homozygous for Arg16 were reported
to have lower lung function.21 In the British 1958
birth cohort study, among the members (n = 8018)
who contributed DNA samples at the 45-year follow-
up, the common polymorphisms Arg16Gly and Gln27
Glu were significantly associated with persistence of
asthmatic symptoms from childhood to middle age.
Collectively, both the CCL5 -28C>G and the ADRB2
Arg16Gly genotypes could play important roles in the
expression of the distinct characteristics of the
asthma clusters.
In this study, the same allele at CCL5 was associ-
ated with distinct clusters (clusters A, B and D). The
phenotypic differences between these clusters could
be caused by additional independent genetic associa-
tion including the ADRB2 Arg16Gly genotype. Envi-
ronmental influences also play a role. Among clusters
A, B, and D, cluster B was characterized by a highly
atopic condition that is the strongest risk factor for
asthma. In contrast, cluster D was characterized by
higher frequency of ever-smokers with relatively high
pack-years. Environmental exposure to tobacco
smoke is also known to be an independent risk factor
for asthma other than respiratory infection and
atopy.24 Therefore, given that allergic diathesis or
smoking could have an enormous influence on the
genetic determinants of asthma, the presence or ab-
sence of an interaction of the CCL5 -28G allele with
the ADRB2 genotype, allergic diathesis, or smoking
could have had a significant impact on shaping these
phenotypic characteristics in clusters A, B, or cluster
D. Conversely, cluster F, which was characterized by
late-onset moderate asthma, was associated with nei-
ther the CCL5 -28G allele nor the ADRB2 Gly16 al-
lele. This indicates that late-onset asthma may itself
comprise more than 1 clinical phenotype, which en-
compasses different disease variants with different
genetic components.
It is generally believed that patients with longstand-
ing asthma have more severe airflow limitation than
do those with late-onset asthma. Indeed, in our study,
when all patients were analyzed together, linear re-
Kaneko Y et al.
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gression analysis adjusted for sex, age, and smoking
showed a strong association between duration of the
disease and severity of airflow obstruction (β, -0.148;
t, -4.804; p < 0.0001). However, our study clearly iden-
tified both a group of asthma patients with severely
impaired lung function but rather short duration of
the disease (cluster D) and a group of asthma pa-
tients with normal lung function and long term dura-
tion of the disease (cluster B). Although the asthma
in some of the patients in cluster D could have started
as mild childhood asthma that was never appropri-
ately diagnosed or was clinically silent, we believe
that our finding suggests that analyzing risk factors
for impaired lung function in asthmatic patients by
using the overall asthma population may be mislead-
ing and thus emphasizes the importance of careful
asthma sub-typing in epidemiology studies, which
will have important implications for understanding
the pathogenesis of asthma.
Well-established clinical and physiological pheno-
types relevant to asthma include those defined by the
presence of atopy, the presence of airflow obstruc-
tion, and the age of asthma onset.4 The results of re-
cent studies on defining asthma phenotypes by use of
exploratory methods such as a clustering approach
are consistent with observations from clinical prac-
tice, showing the importance of age at onset, airflow
obstruction, and allergic diathesis in phenotyping
asthma.1-3 Therefore, the decisions made here about
which phenotypic variables to include were made
based on clinical judgment of relevance. Rather than
using a priori cutoff values for age at onset, baseline
lung function, and levels of total serum IgE, we ap-
plied cluster analysis, and thus the identified clusters
conform to shared phonotypical features. However,
we used a very limited range of variables to describe
asthma heterogeneity, and we recognize that the
choice of variables could have affected the outcome
and thus is not immune to a priori assumptions. It is,
therefore, more appropriate to consider our selection
approach as one that is hypothesis-driven rather than
unbiased. Because it remains to be seen whether one
of these approaches, an unbiased approach such as
cluster analysis or a biased approach relying on clini-
cal characteristics, is superior in identifying subtypes
or whether these approaches are separately informa-
tive and complementary, an attempt to validate our
findings of specific subtypes using these or similar
methods in other well-phenotyped asthma cohorts
should be performed.
Obesity has a significant impact on asthma risk, se-
verity, and control.25 Moore et al. reported that an un-
supervised hierarchical cluster analysis identified a
group of nonatopic women who were primarily obese
as a distinct phenotype of asthma.1 Thirty-seven per-
cent of the total cohort of their study had a BMI >30.
In contrast, only 5.7% of participants in the current
study had a BMI >30. In addition, data from a nation-
wide population-based cross-sectional survey of adult
asthma prevalence in Japan (N = 22,962; age range,
20-79 years) showed that the prevalence of obesity
(BMI 30.0) was very low (men, 3.0%; women,
2.3%).26 Therefore, we believe that, at least in the
Japanese population, the asthma phenotype related to
obese women does not constitute a large proportion
of the disease heterogeneity of asthma.
In our study, to judge the age at onset of asthma as
accurately as possible, a detailed history of each pa-
tient’s episodes of dyspnea, wheezing, or cough dur-
ing childhood and puberty was taken. In case of un-
certainty, the earliest respiratory symptoms were
taken into account and the age at onset of asthma
symptoms was used for the calculation of the dura-
tion of asthma. A study that examined age at onset of
asthma in 4335 Japanese adult asthmatics found that
26.3% of those individuals developed the disease be-
fore the age of 20 years, whereas 73.8% developed it
at the age of 20 years or older.27 This variable age at
onset of adult asthma is very similar to those of our
study, which may validate the data on age at onset of
asthma based on self-reporting in our study. In addi-
tion, a previous analysis revealed that adults reported
important childhood events with high consistency re-
gardless of symptom status.28 However, it should be
acknowledged that it is virtually impossible to distin-
guish with any certainty recrudescent from incident
asthma cases in an adult population. Even though a
number of asthma patients whom we designated as
having late-onset asthma might have developed the
disease in childhood, it seems unlikely that the par-
ticular genotypes examined in the current study con-
tributed to this recall bias. We therefore believe that
the observed difference in the frequency of the CCL5
-28G allele or the ADRB2 Gly16 allele among the sub-
groups of asthma cannot be attributed to recall bias.
In conclusion, our clinic-based cluster analysis
identified meaningful adult asthma phenotypes linked
to the functional CCL5 -28C>G andor ADRB2 Arg16
Gly SNP. Our analysis is best seen as hypothesis-
generating rather than hypothesis-solving, and an at-
tempt to validate these findings of specific subtypes
using these or similar methods in other well-
phenotyped asthma cohorts should be performed.
The classification of patients with asthma by pheno-
type will facilitate future research to identify biomark-
ers for disease phenotypes and to test novel therapeu-
tic targets and phenotype-specific treatments.
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